When Your Genome Costs Less Than Your iPhone: The Beautiful, Terrifying Future of DNA Sequencing
By Jo Best,
Tech Republic
| 06. 05. 2015
Untitled Document
Dan Lane has always had a keen interest in the next big thing. He owned an early set of Google Glass, got his first RFID implant 10 years ago. Working in technology, he'd always been curious to try out the latest piece of kit or new service. So when 23andMe, a company that offers customers insight into their own DNA, opened up in the UK, he decided he'd give that a try too.
23andMe works like this: you get sent a small tube in the post, you spit into it, and send it away to be analysed. That little sample of saliva may not seem like much, but it holds a few of your cheek cells, each of which contains your entire genome—all the DNA that makes you, you. A few weeks later after the tube arrives, 23andMe sends you back a personalised interpretation of your DNA.
Services like 23andMe can unpick your genome to discover information on a range of traits: how you react to certain drugs; your risk of developing particular diseases; what characteristics you might...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...